Gf Fund Management Co. Ltd. Crispr Therapeutics Ag Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,186 shares of CRSP stock, worth $96,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,186
Previous 1,792
21.99%
Holding current value
$96,730
Previous $70.5 Million
5.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
480Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$450 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$269 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$168 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$123 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$112 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.45B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....